Compare MDU & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | BLLN |
|---|---|---|
| Founded | 1924 | 2016 |
| Country | United States | United States |
| Employees | N/A | 713 |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.2B |
| IPO Year | 1994 | N/A |
| Metric | MDU | BLLN |
|---|---|---|
| Price | $21.17 | $129.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $21.67 | ★ $126.71 |
| AVG Volume (30 Days) | ★ 1.6M | 706.5K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $1,875,066,000.00 | N/A |
| Revenue This Year | $7.52 | $46.29 |
| Revenue Next Year | $6.00 | $30.14 |
| P/E Ratio | $54.49 | ★ N/A |
| Revenue Growth | ★ 6.66 | N/A |
| 52 Week Low | $15.76 | $61.96 |
| 52 Week High | $22.98 | $138.70 |
| Indicator | MDU | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 67.38 |
| Support Level | $19.99 | $79.07 |
| Resistance Level | $21.27 | $138.70 |
| Average True Range (ATR) | 0.42 | 6.72 |
| MACD | 0.04 | 0.30 |
| Stochastic Oscillator | 53.69 | 99.04 |
MDU Resources Group Inc is a pure-play regulated energy delivery business. It is organized into three reportable business segments: Electric, Natural Gas Distribution, and Pipeline. Maximum revenue is generated from the Pipeline segment, which provides natural gas transportation and underground storage services through a FERC-regulated pipeline system mainly in the Rocky Mountain and northern Great Plains regions of the United States. This segment also provides non-regulated energy-related services, including cathodic protection. The electric segment generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming, and the natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.